| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Revenue | 6,530,000 | 18,925,000 | - |
| Cost of revenue | 3,858,000 | 10,341,000 | - |
| Research and development | 1,724,000 | 3,936,000 | - |
| Selling, general and administrative | 3,297,000 | 9,085,000 | - |
| Other expense, net | -4,000 | -8,761,000 | - |
| Change in fair value of warrant liability | 173,000 | 3,578,000 | - |
| Change in fair value of derivative liability | 0 | 101,000 | - |
| Change in fair value of earnout liability | -50,000 | 1,770,000 | - |
| Interest expense, net | -930,000 | -2,639,000 | - |
| Revenue | - | - | 10,649,930 |
| Cost of revenue | - | - | 5,208,318 |
| Research and development | - | - | 2,691,704 |
| Selling, general and administrative | - | - | 6,486,697 |
| Other expense (income), net | - | - | -8,770,514 |
| Change in fair value of warrant liability | - | - | 3,581,122 |
| Change in fair value of derivative liability | - | - | 101,300 |
| Change in fair value of earnout liability | - | - | 2,070,000 |
| Interest expense, net | - | - | -1,635,014 |
| Income tax expense | - | - | 2,782 |
| Income tax benefit | 0 | -1,000 | - |
| Net loss | -3,406,000 | -1,388,079 | -19,694,921 |
| Depreciation and amortization | 20,000 | 15,526 | 115,474 |
| Debt modification expense | - | - | 90,000 |
| Stock-based compensation | 381,000 | 282,279 | 518,721 |
| Provision for credit losses | - | 0 | 0 |
| Fair value of common stock issued in exchange for services and in connection with non-redemption agreements | - | 0 | 0 |
| Loss on issuance of the lynrock lake term loan | 0 | 6,640,000 | - |
| Debt modification expense | 0 | -90,000 | - |
| Loss on issuance of common stock in connection with a subscription agreement | - | 0 | 0 |
| Warrant modification expense | - | 0 | 0 |
| Loss on issuance of the lynrock lake term loan | - | - | 6,640,384 |
| Loss on debt extinguishment | 0 | 53 | -2,080,053 |
| Non-cash interest | 677,000 | 409,903 | 749,097 |
| Non-cash operating lease | 12,000 | 11,988 | 31,012 |
| Change in fair value of warrant liability | 173,000 | -3,122 | 3,581,122 |
| Change in fair value of derivative liability | 0 | -300 | 101,300 |
| Change in fair value of earnout liability | -50,000 | -300,000 | 2,070,000 |
| Accounts receivable | 572,000 | 2,537,413 | 3,176,587 |
| Inventory | 1,799,000 | -176,508 | 2,101,508 |
| Prepaid expenses and other current assets | 247,000 | 5,714 | 298,286 |
| Accounts payable | -495,000 | 1,380,450 | 1,071,550 |
| Accrued expenses and other current liabilities | 468,000 | -1,410,098 | 1,856,098 |
| Deferred revenue | - | - | -25,436 |
| Other liabilities | 1,208,000 | 265,021 | 798,979 |
| Net cash used in operating activities | -3,654,000 | -3,101,428 | -5,857,572 |
| Purchases of property and equipment | 17,000 | 77,182 | 46,818 |
| Net cash used in investing activities | -17,000 | -77,182 | -46,818 |
| Proceeds from sale of common stock and warrants | 155,000 | 16,889,759 | 679,241 |
| Proceeds from issuance of common stock pursuant to a subscription agreement | - | 0 | 0 |
| Proceeds from warrant exercises | - | 23,378 | 531,622 |
| Proceeds from long-term debt, net of issuance costs | 0 | -144,000 | 15,000,000 |
| Repayment of long-term debt | 9,000 | 5,013,984 | 4,688,016 |
| Repayment of bridge loans | - | 0 | 0 |
| Payment of deferred issuance costs | - | - | 150,000 |
| Repurchase of warrant from yorkville | - | -5,000,000 | - |
| Proceeds from the merger, net of transaction costs | - | 0 | 0 |
| Cash paid for stock issuance costs | 232,000 | 0 | - |
| Repurchase of warrant from yorkville | - | - | 5,000,000 |
| Proceeds from stock option exercises | 245,000 | 161 | 74,839 |
| Net cash provided by financing activities | 159,000 | 11,905,314 | 6,447,686 |
| Net increase in cash and cash equivalents and restricted cash and cash equivalents | -3,512,000 | 8,726,704 | 543,296 |
| Cash and cash equivalents at beginning of period | - | - | 1,192,104 |
| Cash and cash equivalents and restricted cash and cash equivalents, beginning balance | 1,735,400 | 1,735,400 | - |
| Cash and cash equivalents at end of period | - | - | 1,735,400 |
| Cash and cash equivalents and restricted cash and cash equivalents, ending balance | 6,950,000 | 10,462,000 | - |
QT IMAGING HOLDINGS, INC. (QTIWW)
QT IMAGING HOLDINGS, INC. (QTIWW)